Sign In
Buy SNY
$43.98
-0.680 (-1.52%)
At Close: Jul 20, 2026
Sanofi (SNY) CEO Paul Hudson on Q3 2021 Results - Earnings Call Transcript
02:06pm, Thursday, 28'th Oct 2021
Sanofi (SNY) CEO Paul Hudson on Q3 2021 Results - Earnings Call Transcript
Sanofi (SNY) Q3 Earnings Beat, Sales Miss, 2021 EPS View Up
12:13pm, Thursday, 28'th Oct 2021
Sanofi (SNY) beats third-quarter estimates for earnings but misses the same for sales. It raises earnings growth guidance range for the year.
Drugmaker Sanofi raises 2021 profit guidance again after Q3 beat
01:55am, Thursday, 28'th Oct 2021
French drugmaker Sanofi again raised its profit guidance for 2021 as its blockbuster eczema drug Dupixent and flu vaccines helped it beat market forecasts in the third quarter.
If I Could Only Own 1 Healthcare Stock, This Is What It Would Be
09:25am, Thursday, 21'st Oct 2021
Investing gets simple if you have to put all of your eggs in one basket.
Benjamin Graham's Formula Nails 26 Top Value Dividend Winners For October
05:58am, Wednesday, 13'th Oct 2021
"Benjamin Graham Value Stocks match the criteria Benjamin Graham followed." - YCharts Value Screener. 35 Graham formula picks screened by YCharts October 8, 2021 are based on Graham's established crit
Will Chart Analysts Notice Bad Omen on Sanofi's Chart
11:52am, Friday, 08'th Oct 2021
If history is any guide, there may be trouble ahead for shares of Sanofi(NASDAQ:SNY). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
Giving Moderna's COVID-19 booster at the same time as Sanofi's flu is safe and effective
10:38am, Friday, 08'th Oct 2021
U.S.-listed shares of Sanofi SNY, +0.37% gained 0.4% in trading on Friday after it announced that co-administering a flu shot with Moderna Inc.'s MRNA, -3.33% experimental COVID-19 booster in seniors
EXG: American Market Continues To Be Overvalued, Go Abroad With This Fund
06:13am, Wednesday, 06'th Oct 2021
EXG: American Market Continues To Be Overvalued, Go Abroad With This Fund
After COVID-19, Could This Be the Next Billion-Dollar Vaccine Market?
06:00am, Monday, 04'th Oct 2021
Three healthcare giants are vying for the prize.
Here's a High-Yield Dividend Stock Wall Street Thinks Could Jump 26% Within 12 Months
05:52am, Monday, 04'th Oct 2021
There's plenty to like with this big pharma stock -- but a few problem spots, too.
3 Big Drug/Biotech Stocks to Boost Your Portfolio's Health
11:08am, Thursday, 30'th Sep 2021
Sanofi (SNY), Pfizer (PFE) and Novo Nordisk (NVO) are three large drugmakers that are worth betting on in the current scenario.
Are Investors Undervaluing Sanofi (SNY) Right Now?
01:33pm, Wednesday, 29'th Sep 2021
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Sanofi Stops Work On Its mRNA COVID-19 Vaccine: What You Need To Know
07:53am, Tuesday, 28'th Sep 2021
Sanofi SA (NASDAQ: SNY) is dropping plans for its mRNA-based COVID-19 vaccine because it believes it will be too late in reaching the market, STAT news reported. Sanofi says that the market is well-
Sanofi halts development of its Covid mRNA vaccine
07:39am, Tuesday, 28'th Sep 2021
CNBC's Charlotte Reed reports on Sanofi's announcement that its Covid-19 mRNA vaccine will not pursue phase 3 trials despite positive initial results. Instead the French pharma firm said it wants to f
Sanofi ditches mRNA COVID-19 vaccine amid rivals' success
05:10am, Tuesday, 28'th Sep 2021
Sanofi is dropping plans for its own mRNA-based COVID-19 vaccine because of the dominant role of the BioNTech-Pfizer alliance as well as Moderna in the fight against the pandemic, the company said on
